Moderna Inc has announced that it is in the process of developing a new single-dose vaccine that combined a booster Covid-19 vaccine dose and a shot against flu. “Today we are announcing the first step in our novel respiratory vaccine program with the development of a single-dose vaccine that combines a booster against Covid-19 and a booster against flu," said Stéphane Bancel, Chief Executive Officer of Moderna. "We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial.
We believe this is just the beginning of a new age of information-based medicines," she added. During its R&D day, the company also provided updates on its ongoing mid-stage trial